SUMMARY The coronavirus disease 2019 (COVID-19) pandemic, caused by severe acute
respiratory disease coronavirus 2 (SARS-CoV-2), has led to millions of confirmed cases and …

Introduction: The gold standard for diagnosis of coronavirus disease 2019 (COVID-19) is
detecting severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) by reverse …

Lateral-flow assays (LFAs) are rapid and inexpensive, yet they are nearly 1,000-fold less
sensitive than laboratory-based tests. Here we show that plasmonically active antibody …

Individuals with primary and pharmacologic B cell deficiencies have high rates of severe
disease and mortality from coronavirus disease 2019 (COVID-19), but the immune …

The first emergency-use authorizations for COVID-19 vaccines were granted by the Food
and Drug Administration in December 2020, and clinical trials for the approval of more …

Characterizing the interactions that SARS-CoV-2 viral RNAs make with host cell proteins
during infection can improve our understanding of viral RNA functions and the host innate …

Regulation of viral RNA biogenesis is fundamental to productive SARS-CoV-2 infection. To
characterize host RNA-binding proteins (RBPs) involved in this process, we biochemically …

Neutralizing antibodies are a major correlate of protection for many viruses including the
novel coronavirus SARS-CoV-2. Thus, vaccine candidates should potently induce …

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic has created
an urgent need for new technologies to treat COVID-19. Here we report a 2′-fluoro …

Importance Understanding the long-term immune response against SARS-CoV-2 infection
in children is crucial to optimize vaccination strategies. Although it is known that SARS-CoV …